Literature DB >> 7073107

Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare.

C H Ahn, J W McLarty, S S Ahn, S I Ahn, G A Hurst.   

Abstract

A study of 271 patients infected with Mycobacterium kansasii and 226 patients with Mycobacterium avium-intracellulare complex has led to the proposal of new diagnostic criteria. These criteria, based on the presence or absence of cavitation and on the duration of sputum positivity after initiation of therapy, are proposed to more accurately distinguish colonizations from active invasion of tissue than the current diagnostic criteria.

Entities:  

Mesh：

Year:  1982        PMID： 7073107     DOI： 10.1164/arrd.1982.125.4.388

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


  16 in total

1.  Assessment of cross-reactivity between Mycobacterium bovis and M. kansasii ESAT-6 and CFP-10 at the T-cell epitope level.

Authors:  H Martin Vordermeier; Jemma Brown; Paul J Cockle; Willeke P J Franken; Jan Wouter Drijfhout; Sandra M Arend; Tom H M Ottenhoff; Keith Jahans; R Glyn Hewinson
Journal:  Clin Vaccine Immunol       Date:  2007-08-01

Review 2.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

3.  Niacin-positive Mycobacterium kansasii isolated from immunocompromised patients.

Authors:  I Nachamkin; R R MacGregor; J L Staneck; A Y Tsang; J C Denner; M Willner; S Barbagallo
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

4.  Mycobacterium kansasii and Pneumocystis carinii pneumonia in a patient with the acquired immunodeficiency syndrome.

Authors:  U Vurma-Rapp; F Colla; M Flepp
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

5.  Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies.

Authors:  F Alcaide; I Richter; C Bernasconi; B Springer; C Hagenau; R Schulze-Röbbecke; E Tortoli; R Martín; E C Böttger; A Telenti
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

6.  Prospective study of mycobacterial infections in patients with cystic fibrosis.

Authors:  L Hjelte; B Petrini; G Källenius; B Strandvik
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

Review 7.  Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective.

Authors:  Won-Jung Koh; O Jung Kwon; Kyung Soo Lee
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

8.  Clinical characteristics and treatment outcomes of Mycobacterium kansasii lung disease in Korea.

Authors:  Hye Kyeong Park; Won-Jung Koh; Tae Sun Shim; O Jung Kwon
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

9.  Isolation of mycobacteria from patients seropositive for the human immunodeficiency virus (HIV) in south east England: 1984-92.

Authors:  M D Yates; A Pozniak; J M Grange
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

Review 10.  Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients.

Authors:  Won-Jung Koh; O Jung Kwon; Kyung Soo Lee
Journal:  Korean J Radiol       Date:  2002 Jul-Sep       Impact factor: 3.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.